The cyclin-dependent kinase 4/6 inhibitor, abemaciclib, exerts dose-dependent cytostatic and cytocidal effects and induces autophagy in multiple myeloma cells.
| Image |  |
|---|---|
| Description | scientific article published on 18 September 2017 |
| Author/s |
author: Noriyoshi Iriyama |
| Publication date | September 18, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |